FDA WARNING_LETTER - Gutman Brothers, Ltd.
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
On August 8, 2012, the FDA inspected Gutman Brothers, Ltd.'s dairy operation in New Holland, Pennsylvania, and found violations of the Federal Food, Drug, and Cosmetic Act. Two bob veal calves sold for slaughter were adulterated due to unsafe new animal drug residues.
Specifically, a calf sold on March 26, 2012, had sulfamethazine residues of 25.715 ppm in the liver and 18.979 ppm in muscle tissue. Another calf sold on April 2, 2012, had 21.797 ppm in the liver and 21.733 ppm in muscle tissue. These levels exceed the FDA tolerance of 0.1 ppm for sulfamethazine in cattle tissues (21 C.F.R. 556.670). Furthermore, FDA has no tolerance for Sustain III Calf Bolus (sulfamethazine) in calves under one month or on an all-milk diet (21 C.F.R. 520.2260b). This constitutes adulteration under 21 U.S.C. 342(a)(2)(C)(ii).
The operation also held animals under insanitary conditions, failing to maintain treatment records, which may lead to harmful drug residues entering the food supply, violating 21 U.S.C.
- Company
- Gutman Brothers, Ltd.
- Product Type
- Drugs
ID · 9ebe63c8-4726-4f6b-a37b-d6f9235da6ba
Full citation text and observation details available on the Dashboard.